InvestorsHub Logo

Talc Moan

06/28/10 9:23 AM

#45064 RE: ActivClient #45063

You are acting quite surprised. The board has been discussing this massacre for quite some time.

Smitter SMTT

selfactualize

06/29/10 3:35 AM

#45076 RE: ActivClient #45063

FDA Appeal Decision Indicates That Genasense(R) Approval In Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial

http://www.medicalnewstoday.com/articles/141539.php

....In a decision issued in response to an appeal filed by Genta in December 2008, CDER concluded that new information submitted by the Company in its amended New Drug Application (NDA) was insufficient, and the Agency has recommended conducting a confirmatory clinical trial...........